- Entry
- $3.34
- Now
- $3.56 +6.5%
- Target
- —
- Score
- —
**Key Points:** * **Read the words I bolded in the 8-K below.** In my opinion, it was completely unnecessary for the FDA reviewer to make this citation. All the excellent documentation/evidence was already provided in the ANDA submission. **To pass this hurdle all that is needed is for the manufacturers of the "vial tip" to sign a certification.** ***C'mon ... really!*** * After KETAFREE is approved, ask yourself why any company would continue to purchase ketamine containing the BZT toxin. …
— ORIGINAL POST ·
NRx Pharmaceuticals (NRXP) - Imminent Catalyst - 8-K dropped today (follow-up to yesterday's post - I encourage you to check it out). The stock is up nicely this morning, as a result! One of my favorite companies to hold. This company is a winner ... now ... and longer term.
· r/pennystocks
· Aug 7, 2026